PGNY

PGNY

USD

Progyny Inc. Common Stock

$18.590+0.310 (1.696%)

Reaalajas hind

Healthcare
Healthcare Plans
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$18.280

Kõrge

$18.840

Madal

$18.030

Maht

0.61M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.6B

Tööstusharu

Healthcare Plans

Riik

United States

Kauplemisstatistika

Keskmine maht

1.31M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $13.39Praegune $18.590Kõrge $26.76

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 3. nov 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

PGNY Stock Analysis: What Progyny's Recent Moves Mean for Short-Term Traders

What's Happening With Progyny Right Now

Progyny (PGNY) is showing signs of exhaustion after a rough few months. The stock closed at $18.43 on November 3rd, down from $23 in early August--a nearly 20% slide over the past three months. The chart tells a clear story: persistent selling pressure with occasional spikes when news hits. Volume exploded to over 7.4 million shares on October 16th when the stock jumped 4.7% in one day, only to crash

Seotud uudised

GlobeNewswire

Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended September 30,

Vaata rohkem
GlobeNewswire

Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs

Vaata rohkem
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
BusinessWire

Transcarent Experience Store Expansion: More Options for Women's Health

Maven Clinic, Midi Health, and Progyny provide support for menopause, perimenopause, and family building for Transcarent Members Easy access through WayFinding™ AI experience is a gamechanger Transcarent, the

Vaata rohkem
Transcarent Experience Store Expansion: More Options for Women's Health
GlobeNewswire

Progyny CEO Named World Economic Forum Champion for Women's Health

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a

Vaata rohkem
Progyny CEO Named World Economic Forum Champion for Women's Health

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 4. nov 2025, 17:26

LangevNeutraalneTõusev

64.3% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Mõõdukas
Kauplemisjuhend

Sisenemispunkt

$18.21

Võta kasum

$19.66

Peata kahjum

$16.58

Põhitegurid

RSI 71.8 viitab ülemüüdud tingimustele
PDI 12.5 on MDI 4.9 kohal ADX-iga 20.3, mis viitab tõusutrendile
Kauplemismaht on 6.9x keskmisest (14,478), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0379 on signaalijoone 0.0101 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.